The industry veteran brings more than 30 years of experience across research and development, commercialization, and market access.
DURHAM, N.C., Oct. 13, 2023 (Globe Newswire) — Fortrea (Nasdaq: FTRE), the world’s leading contract research organization (CRO), today named Dr. John Doyle as its new President of Consulting. announced. As part of Fortrea’s leadership team, Mr. Doyle will lead a team of consultants and advisors with expertise ranging from early development to lifecycle management.
“Pharmaceutical and biotechnology innovators must constantly navigate complex and rapidly changing business and regulatory environments to achieve their missions,” said Tom Pike, Chairman and CEO of Fortrea. says. “John has extensive industry knowledge and unique technical skills that add tremendous value to our clients. He has an impressive track record of building and operating differentiated consulting organizations that drive innovation and growth. John leads a team of truly talented professionals with deep knowledge of the scientific method and regulatory requirements in jurisdictions around the world. They make life-changing treatments more accessible to patients. I am confident that we will provide a solution that will bring you fast.”
Dr. Doyle will lead Fortrea’s consulting organization, which includes drug development, commercialization and market access advisors with scientific, regulatory and operational expertise spanning more than 13 countries. Its solutions include clinical development and regulatory strategy, real-world evidence, market access, health economics and outcomes research (HEOR), medical writing and publishing, and specialized expertise such as pediatric plan development and orphan drug designation. Services included.
“The biopharmaceutical industry is constantly working to advance science to improve patient outcomes, and Fortrea is uniquely positioned to help.” said Dr. Doyle. “We are honored to join Fortrea and excited to join the company at such a critical time in its first few months. We can leverage Rare’s strong capabilities to create innovative solutions for our customers.”
Dr. Doyle is an accomplished life science advisor and epidemiologist who specializes in studying the risks, benefits, and value of medical interventions. He brings over 30 years of clinical research experience to his Fortrea and has published over 50 peer-reviewed papers and his 100 conference abstracts. He joins Fortrea from Exponent, a Silicon Valley-based science and engineering consulting firm where he led the company’s health sciences business. Previously, Dr. Doyle led Pfizer’s Global Healthcare Innovation Center, focused on optimizing fair and affordable access to Pfizer’s medicines and vaccines. He earned a PhD in Epidemiology and a Master of Public Health from Columbia University’s Mailman School of Public Health, and a Bachelor of Science in Business Administration and Applied Economics with a concentration in Life Sciences from Cornell University. Dr. Doyle has been a faculty member at the Columbia University Mailman School of Public Health since 2005.
About Fortrea
Fortrea (NASDAQ: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and leading biopharmaceutical, medical device, and diagnostic companies to advance medical innovations that accelerate life-changing treatments for patients in need. Fortrea provides Phase I-IV clinical trial management, clinical pharmacology, differentiated technology clinical trial solutions, and post-approval services.
Fortrea’s solutions leverage 30 years of experience across more than 20 therapeutic areas, a passion for scientific rigor, exceptional insight, and a strong network of clinical sites. Our talented and diverse team of more than 19,000 employees in more than 90 countries scales to deliver focused, agile solutions to our customers around the world.
Learn more about how Fortrea is becoming a force for pipeline-to-patient transformation at Fortrea.com. Also, follow us on LinkedIn and X (formerly Twitter) @Fortrea.
Fortrea contact information:
Fortrea Media: Sue Zaranek – 919-943-5422, media@fortrea.com
Fortrea Media: Kate Dillon – 646-818-9115, kdillon@prosek.com